Cardiovascular Disease Archives - Robard Corporation

Can GLP-1 RAs Mitigate the Risks of Cardiovascular Disease?

October 22, 2024
Blog, Cardiovascular Disease, GLP-1, Type 2 Diabetes, Weight Loss Medications

GLP-1 RAs are now known to have cardiovascular benefits in addition to glycemic control and weight loss. Glucagon-like peptide-1 receptor agents (GLP-1 RAs) are now demonstrating efficacy for mitigating the risks of cardiovascular disease.1 While the positive effects of GLP-1s…

Obesity and Cardiovascular Disease: What are the Challenges and the Weight Management Strategies to Mitigate Risk?

June 18, 2024
Blog, Cardiology, Cardiovascular Disease

The risks of cardiovascular disease related to obesity can be managed via intentional weight loss. Obesity and cardiovascular disease (CVD) are each considered a chronic health condition by the World Obesity Federation, a group that has partnered with the World…